Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.59%133.44B | -0.23%83.28B | -1.04%36.64B | -13.76%181.3B | -15.88%134.23B | -18.46%83.47B | -16.22%37.02B | -10.12%210.22B | -9.48%159.58B | -8.50%102.37B |
| Operating income | -0.59%133.44B | -0.23%83.28B | -1.04%36.64B | -13.76%181.3B | -15.88%134.23B | -18.46%83.47B | -16.22%37.02B | -10.12%210.22B | -9.48%159.58B | -8.50%102.37B |
| Cost of sales | ---- | 4.15%-67.3B | ---- | 13.99%-148.59B | ---- | 17.17%-70.22B | ---- | 10.96%-172.77B | ---- | 6.06%-84.77B |
| Operating expenses | 3.32%-105.57B | 4.15%-67.3B | 4.16%-29.71B | 13.99%-148.59B | 15.53%-109.19B | 17.17%-70.22B | 16.75%-31B | 10.96%-172.77B | 9.08%-129.27B | 6.06%-84.77B |
| Gross profit | 11.33%27.88B | 20.57%15.98B | 15.06%6.93B | -12.65%32.71B | -17.39%25.04B | -24.72%13.25B | -13.37%6.02B | -6.02%37.45B | -11.11%30.31B | -18.68%17.61B |
| Selling expenses | 1.49%-2.92B | -1.95%-1.93B | -10.74%-1.04B | -6.06%-3.92B | -4.04%-2.96B | -4.38%-1.89B | -2.65%-936.73M | -1.73%-3.69B | -7.15%-2.85B | -4.05%-1.81B |
| Administrative expenses | 3.95%-9.52B | 9.88%-8.93B | -0.26%-3.19B | 2.36%-20.62B | -0.25%-9.91B | -4.59%-9.91B | 1.81%-3.18B | -0.56%-21.12B | -3.95%-9.89B | -3.73%-9.48B |
| Research and development expenses | 7.88%-4.04B | ---- | 4.05%-1.02B | ---- | 4.38%-4.38B | ---- | -0.94%-1.07B | ---- | -17.29%-4.58B | ---- |
| Profit from asset sales | 539.59%97.73M | ---- | -22.31%53.94M | ---- | -59.68%15.28M | ---- | 724.12%69.42M | ---- | -96.19%37.9M | ---- |
| Revaluation surplus | 554.49%333.33M | ---- | 16.47%-63.08M | ---- | 90.57%-73.34M | ---- | -409.38%-75.52M | ---- | 63.82%-777.95M | ---- |
| -Changes in the fair value of other assets | 554.49%333.33M | ---- | 16.47%-63.08M | ---- | 90.57%-73.34M | ---- | -409.38%-75.52M | ---- | 63.82%-777.95M | ---- |
| Impairment and provision | -151.19%-662.39M | -121.41%-433.36M | -670.63%-31.65M | -1,010.22%-629.68M | -33.39%-263.7M | 24.95%-195.72M | 32.03%5.55M | 350.97%69.18M | -205.11%-197.69M | -325.65%-260.79M |
| -Other impairment is provision | -151.19%-662.39M | -121.41%-433.36M | -670.63%-31.65M | -1,010.22%-629.68M | -33.39%-263.7M | 24.95%-195.72M | 32.03%5.55M | 350.97%69.18M | -205.11%-197.69M | -325.65%-260.79M |
| Special items of operating profit | 34.87%2.68B | ---- | 37.60%669.25M | ---- | -8.56%1.99B | ---- | -15.39%486.38M | ---- | -54.60%2.18B | ---- |
| Operating profit | 61.39%11.49B | 274.24%4.68B | 136.65%1.64B | -40.65%7.54B | -38.64%7.12B | -79.33%1.25B | -56.72%694.52M | -16.34%12.7B | -39.54%11.6B | -39.13%6.05B |
| Financing cost | 18.26%-3.34B | 6.38%-2.29B | 18.56%-1.17B | 9.42%-4.66B | 0.20%-4.08B | 8.18%-2.44B | 2.24%-1.43B | 12.99%-5.14B | 0.77%-4.09B | ---2.66B |
| Share of profits of associates | ---- | 99.49%680.22M | ---- | -27.87%1.09B | ---- | -65.88%340.98M | ---- | -50.37%1.51B | ---- | -47.67%999.32M |
| Share of profit from joint venture company | ---- | 21.17%-5.51M | ---- | -195.38%-9.91M | ---- | -75.14%-6.99M | ---- | 56.24%-3.36M | ---- | -136.85%-3.99M |
| Special items of earning before tax | ---- | 73.50%2.05B | ---- | 60.20%5.53B | ---- | 2.37%1.18B | ---- | -39.40%3.45B | ---- | 900.63%1.16B |
| Adjustment items of earning before tax | 8.31%-36.03M | ---- | 49.85%-10.13M | ---- | -115.74%-39.3M | ---- | -117.76%-20.2M | ---- | 785.94%249.71M | ---- |
| Earning before tax | 170.89%8.11B | 1,466.48%5.13B | 161.17%465.05M | -24.17%9.49B | -61.39%2.99B | -94.10%327.2M | -402.77%-760.26M | -30.48%12.52B | -48.59%7.76B | -53.66%5.54B |
| Tax | -42.44%-1.54B | -87.34%-1.16B | -124.33%-363.43M | 1.86%-2.08B | 19.24%-1.08B | 45.21%-619.55M | 41.82%-162.01M | 18.69%-2.12B | 46.37%-1.34B | 43.83%-1.13B |
| After-tax profit from continuing operations | 243.63%6.57B | 1,456.17%3.96B | 111.02%101.62M | -28.72%7.41B | -70.20%1.91B | -106.62%-292.35M | -3,268.06%-922.27M | -32.48%10.4B | -49.04%6.42B | -55.65%4.41B |
| Earning after tax | 243.63%6.57B | 1,456.17%3.96B | 111.02%101.62M | -28.72%7.41B | -70.20%1.91B | -106.62%-292.35M | -3,268.06%-922.27M | -32.48%10.4B | -49.04%6.42B | -55.65%4.41B |
| Minority profit | 39.07%3.61B | 64.10%2.39B | 44.75%618.47M | -24.62%4.51B | -36.10%2.6B | -47.00%1.46B | -14.33%427.27M | -9.10%5.99B | -24.80%4.06B | -31.61%2.75B |
| Special items of profit attributable to shareholders | ---- | -19.79%216.67M | ---- | -6.78%514.42M | ---- | 2.18%270.13M | ---- | -19.86%551.81M | ---- | -23.47%264.37M |
| Profit attributable to shareholders | 532.46%2.96B | 167.42%1.36B | 61.70%-516.85M | -38.20%2.39B | -129.08%-684.38M | -243.69%-2.02B | -156.49%-1.35B | -52.48%3.86B | -67.26%2.35B | -74.90%1.4B |
| Basic earnings per share | 171.97%0.172 | -38.21%0.283 | -243.98%-0.239 | -52.49%0.458 | -74.96%0.166 | |||||
| Diluted earnings per share | 171.97%0.172 | -37.11%0.283 | -243.98%-0.239 | -53.32%0.45 | -74.96%0.166 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.